Advanced company searchLink opens in new window

KLAY BIOTECH LIMITED

Company number 13063396

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
22 Aug 2024 AA Total exemption full accounts made up to 31 December 2023
13 Feb 2024 AD01 Registered office address changed from 35 Ballards Lane London N3 1XW United Kingdom to 73 Cornhill London EC3V 3QQ on 13 February 2024
06 Dec 2023 CS01 Confirmation statement made on 3 December 2023 with no updates
08 Nov 2023 TM01 Termination of appointment of Jeremy Littman as a director on 17 October 2023
14 Jul 2023 AA Total exemption full accounts made up to 31 December 2022
08 Dec 2022 CS01 Confirmation statement made on 3 December 2022 with updates
25 Nov 2022 CH01 Director's details changed for Mr Jeremy Littman on 1 November 2022
30 Aug 2022 SH01 Statement of capital following an allotment of shares on 23 August 2022
  • GBP 110.57
09 Aug 2022 AA Total exemption full accounts made up to 31 December 2021
11 May 2022 SH08 Change of share class name or designation
11 May 2022 SH01 Statement of capital following an allotment of shares on 25 April 2022
  • GBP 100.69
11 May 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
11 May 2022 MA Memorandum and Articles of Association
08 Dec 2021 CS01 Confirmation statement made on 3 December 2021 with updates
18 Jan 2021 CH01 Director's details changed for Mr Noor Ul Owase Jeelani on 7 January 2021
18 Jan 2021 CH01 Director's details changed for Mr David James Dunaway on 7 January 2021
11 Jan 2021 PSC01 Notification of David James Dunaway as a person with significant control on 6 January 2021
11 Jan 2021 PSC01 Notification of Noor Ul Owase Jeelani as a person with significant control on 6 January 2021
11 Jan 2021 PSC07 Cessation of Hector Macleod as a person with significant control on 6 January 2021
11 Jan 2021 AP01 Appointment of Mr Noor Ul Owase Jeelani as a director on 7 January 2021
11 Jan 2021 AP01 Appointment of Mr David James Dunaway as a director on 7 January 2021
11 Jan 2021 AP01 Appointment of Mr Jeremy Littman as a director on 7 January 2021
11 Jan 2021 SH01 Statement of capital following an allotment of shares on 6 January 2021
  • GBP 100
04 Dec 2020 NEWINC Incorporation
Statement of capital on 2020-12-04
  • GBP .01